Drug Tariffs Impact - Search News

News

Trump on US tariff deal with India

Yahoo Finance · 1d

Trump tariffs live updates: Trump signals drug tariffs may come by Aug. 1, announces deal with Indonesia

President Trump has flagged that US tariffs on pharmaceutical imports are likely to kick in on Aug. 1, with duties on semiconductors also in line for implementation then too. “Probably at the end of the month,

Bloomberg on MSN · 2d

Trump Says Drug Tariffs Probable by Aug. 1, Downplays More Deals

President Donald Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month and that levies on semiconductors could come soon as well, suggesting that those import taxes could hit alongside broad “reciprocal” rates set for implementation on Aug.

The Irish Times · 1d

Trump says drug and chip tariffs are likely by August 1st

Additional threat certain to alarm Government already working with EU to reduce impact of threatened 30% general tariff on exports to US

Johnson & Johnson, tariff cost and Outlook

Financial Times · 1d

Johnson & Johnson shares jump after forecasting sales boost and milder tariff impact

Johnson & Johnson shares jumped to their highest price in more than three months as the US-based healthcare group shrugged off the impact of tariffs and raised its earnings and sales guidance for 2025.

Reuters on MSN · 1d

Johnson & Johnson lifts 2025 forecast, halves tariff cost outlook

Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and profit forecast on Wednesday after a strong quarter for flagship cancer drug Darzalex and its cardiovascular devices.

MarketWatch on MSN · 1d

Johnson & Johnson’s stock surges as tariff cost estimate slashed and profit outlook raised

Johnson & Johnson has slashed on Wednesday its estimate for the impact of tariffs in 2025, which it now expects to be around $200 million. The company’s stock is climbing in morning trading, boosted by better-than-expected second-quarter results and raised outlook,

Bloomberg on MSN12h

Novartis CEO on Psoriasis Drug, China Growth, Tariffs, M&A

Novartis AG announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, ...

18hon MSN

Novartis nudges up 2025 outlook, no effect from US tariff threat

Swiss drugmaker Novartis nudged up its full-year earnings forecast on Thursday, citing strong second-quarter sales of key ...

12hon MSN

Novartis CEO: Tariffs are an overhang on the pharmaceutical sector

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

Novartis ‘Moving as Fast as Possible’ to Fully Manufacture Key Drugs in US as Tariffs Near

In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...

Pharmalittle: We’re reading about Trump and pharma tariffs, an abortion pill ruling, and more

President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...

4d

Trump’s tariff war threatens Australia’s Pharmaceutical Benefits Scheme and copper exports

Trump’s latest two industrial sector tariffs—200 percent on pharmaceuticals and 50 percent on copper—have serious ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results